AyuVis Research Limited
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.6Mattributed |
|---|---|
| Latest round | grant, $1.6M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | dallas, tx, usa |
| Industry | unknown |
| Stage | unknown |
| Website | ayuvis.com |
COVID-19- and SARS-induced ARDS AyuVis research is developing a new class of drugs to treat complicated respiratory infections such as BPD and PAP with promising preclinical data. Both of these indications are associated with ARDS, which can be induced by the Corona virus. AyuVis is developing a platform of immunotherapies to prevent and treat l.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $1.6M | undisclosed |
Detected tech stack
Google Cloud CDN, Sentry, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.6M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.6M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | ayuvis.com, read 2026-05-05 |
| Description | self-reported | ayuvis.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.